← Leaderboards
Chunming Liu
University Of Texas Medical Br Galveston
$3,455,693
Attributed
$3,455,693
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $411.1K · FY2005–17$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$3,455,693 · 4
By mechanism
R01$2,831,800 · 2
R21$623,893 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Cancer Cell”
- David Heimbrook · Leidos Biomedical Research, Inc.$394,493,843
- Gregory H Reaman · National Childhood Cancer Foundation$172,801,935
- Richard A Gibbs · Baylor College Of Medicine$159,160,442
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Mary M Horowitz · Medical College Of Wisconsin$153,900,671
- William George Nelson · Johns Hopkins University$111,434,918
Research focus
Cancer CellGenesBasePathway InteractionsCancer EtiologyCell ProliferationAdenomatous Polyposis ColiMalignant NeoplasmsLeadCessation Of LifeMolecularMouse ModelMutationIn VitroColorectal CancerColon CarcinogenesisSignal TransductionFamilyNude MiceTherapeutic AgentsCellsTumor ProgressionResearch StudySignal Pathway
Grant awards (15)
Novel resveratrol analogs and colorectal cancer treatment$312,288
R01 · FY2017 · CA · contact PI
Novel resveratrol analogs and colorectal cancer treatment$312,288
R01 · FY2016 · CA · contact PI
Novel resveratrol analogs and colorectal cancer treatment$312,201
R01 · FY2015 · CA · contact PI
Novel resveratrol analogs and colorectal cancer treatment$301,913
R01 · FY2014 · CA · contact PI
Novel resveratrol analogs and colorectal cancer treatment$311,250
R01 · FY2013 · CA · contact PI
Mechanisms of Wnt/beta-catenin inhibition by resveratrol and its derivatives$193,793
R21 · FY2012 · CA · contact PI
GKLF/Beta-catenin crosstalk in the intestine$249,609
R01 · FY2011 · DK · contact PI
Mechanisms of Wnt/beta-catenin inhibition by resveratrol and its derivatives$161,494
R21 · FY2011 · CA · contact PI
GKLF/Beta-catenin crosstalk in the intestine$250,071
R01 · FY2010 · DK · contact PI
GKLF/Beta-catenin crosstalk in the intestine$254,678
R01 · FY2009 · DK · contact PI
GKLF/Beta-catenin crosstalk in the intestine$4,287
R01 · FY2009 · DK · contact PI
GKLF/Beta-catenin crosstalk in the intestine$258,965
R01 · FY2008 · DK · contact PI
GKLF/Beta-catenin crosstalk in the intestine$264,250
R01 · FY2007 · DK · contact PI
Beta-catenin regulation by tumor suppressor APC$132,706
R21 · FY2006 · CA · contact PI
Beta-catenin regulation by tumor suppressor APC$135,900
R21 · FY2005 · CA